A detailed history of Palo Alto Investors LP transactions in Nevro Corp stock. As of the latest transaction made, Palo Alto Investors LP holds 750,371 shares of NVRO stock, worth $3.87 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
750,371
Previous 750,371 -0.0%
Holding current value
$3.87 Million
Previous $6.32 Million 33.73%
% of portfolio
0.58%
Previous 0.8%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $5.15 Million - $8.11 Million
363,539 Added 93.98%
750,371 $16.1 Million
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $3.65 Million - $5.18 Million
200,573 Added 107.68%
386,832 $7.43 Million
Q2 2023

Aug 14, 2023

BUY
$22.62 - $39.32 $4.21 Million - $7.32 Million
186,259 New
186,259 $4.73 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $183M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.